Colgate-Palmolive (NYSE:CL) insider Daniel B. Marsili sold 19,500 shares of the business’s stock in a transaction dated Tuesday, May 15th. The shares were sold at an average price of $61.69, for a total value of $1,202,955.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Shares of NYSE CL opened at $62.29 on Friday. The company has a debt-to-equity ratio of 64.85, a current ratio of 1.08 and a quick ratio of 0.75. The stock has a market cap of $54.16 billion, a price-to-earnings ratio of 21.70, a price-to-earnings-growth ratio of 2.46 and a beta of 0.75. Colgate-Palmolive has a 12 month low of $61.51 and a 12 month high of $62.40.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, April 27th. The company reported $0.74 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.73 by $0.01. The firm had revenue of $4 billion during the quarter, compared to the consensus estimate of $4.01 billion. Colgate-Palmolive had a return on equity of 1,486.69% and a net margin of 13.30%. The business’s quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.67 earnings per share. sell-side analysts predict that Colgate-Palmolive will post 3.17 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, May 15th. Shareholders of record on Friday, April 20th were paid a dividend of $0.42 per share. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.40. The ex-dividend date of this dividend was Thursday, April 19th. This represents a $1.68 annualized dividend and a yield of 2.70%. Colgate-Palmolive’s payout ratio is presently 58.54%.

A number of hedge funds and other institutional investors have recently modified their holdings of CL. National Planning Corp increased its stake in shares of Colgate-Palmolive by 10.1% in the third quarter. National Planning Corp now owns 13,002 shares of the company’s stock valued at $942,000 after buying an additional 1,191 shares during the period. Argent Trust Co increased its stake in shares of Colgate-Palmolive by 20.8% in the third quarter. Argent Trust Co now owns 4,987 shares of the company’s stock valued at $363,000 after buying an additional 857 shares during the period. Envestnet Asset Management Inc. increased its stake in shares of Colgate-Palmolive by 6.8% in the third quarter. Envestnet Asset Management Inc. now owns 311,902 shares of the company’s stock valued at $22,723,000 after buying an additional 19,868 shares during the period. Northeast Investment Management increased its stake in shares of Colgate-Palmolive by 3.0% in the third quarter. Northeast Investment Management now owns 84,590 shares of the company’s stock valued at $6,162,000 after buying an additional 2,454 shares during the period. Finally, Synovus Financial Corp increased its stake in shares of Colgate-Palmolive by 2.5% in the third quarter. Synovus Financial Corp now owns 74,668 shares of the company’s stock valued at $5,439,000 after buying an additional 1,826 shares during the period. 74.26% of the stock is owned by hedge funds and other institutional investors.

A number of research firms recently commented on CL. Barclays set a $70.00 price target on Colgate-Palmolive and gave the company a “hold” rating in a research note on Monday, April 30th. ValuEngine downgraded Colgate-Palmolive from a “hold” rating to a “sell” rating in a research note on Wednesday, May 2nd. Citigroup dropped their price target on Colgate-Palmolive from $80.00 to $73.00 and set a “neutral” rating for the company in a research note on Tuesday, May 1st. Stifel Nicolaus reaffirmed a “hold” rating and issued a $75.00 price target on shares of Colgate-Palmolive in a research note on Wednesday, April 18th. Finally, Morgan Stanley downgraded Colgate-Palmolive from an “overweight” rating to an “equal weight” rating in a research note on Monday, April 30th. Four investment analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $76.75.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Insider Buying and Selling by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.